These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8362753)

  • 1. Regional hemodynamic effects of perindopril in congestive heart failure.
    Richard C; Thuillez C; Depret J; Auzépy P; Giudicelli JF
    Am Heart J; 1993 Sep; 126(3 Pt 2):782-8. PubMed ID: 8362753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and regional hemodynamic effects of perindopril in congestive heart failure.
    Thuillez C; Richard C; Loueslati H; Auzepy P; Giudicelli JF
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):527-35. PubMed ID: 1691380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
    Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
    J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and regional hemodynamic effects of perindopril in experimental heart failure.
    Medvedev OS; Gorodetskaya EA
    Am Heart J; 1993 Sep; 126(3 Pt 2):764-9. PubMed ID: 8362751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
    Giudicelli JF; Richer C; Richard C; Thuillez C
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure].
    Medvedev OS; Zakharova NV
    Eksp Klin Farmakol; 1994; 57(6):26-9. PubMed ID: 7756952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
    Ogilvie RI; Zborowska-Sluis D
    Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term efficacy of perindopril in severe chronic congestive heart failure.
    Flammang D; Waynberger M; Chassing A
    Am J Cardiol; 1993 Jun; 71(17):48E-56E. PubMed ID: 8328368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
    Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
    Chaignon M; Barrou Z; Ayad M; Guédon J
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular haemodynamic effects of perindopril in essential hypertension.
    Littler W
    Drugs; 1990; 39 Suppl 1():43-8. PubMed ID: 2407492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perindopril and chronic heart failure].
    Bounhoure JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effect of perindopril upon effort capacity in congestive heart failure.
    Zdrenghea D; Angheloiu O; Icusca G; Timiş D
    Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of perindopril in essential hypertension.
    Asmar RG; Pannier B; Laurent ST; Benetos A; Daou J; Safar M
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():35-43; discussion 44. PubMed ID: 2283652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.
    Richer C; Thuillez C; Giudicelli JF
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):94-102. PubMed ID: 2434802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.